Istamet
Istamet

5.49
Normalizes glycemic levels and achieves consistent health outcomes for Diabetes Management by providing dual-action metabolic support to optimize both insulin sensitivity and glucose production.


Availability
In Stock
Delivery Time
Airmail (14-21 days) | Trackable (5-9 days)
Shipped in a discreet, unmarked envelope with all required documents enclosed.

Product Sheet

Active Ingredient(s)
Sitagliptin, Metformin
Reference Brand
Istamet
Product Origin
Generic Brand
Product Form
Tablet
Regulatory Classification
Rx
Primary Category
Diabetes Management
Product Category
Antidiabetic Combination
Pharmacological Class
DPP-4 Inhibitor, Biguanide
Clinical Indications
Type two diabetes support
Manufacturer Description
Istamet is designed to assist in glycemic control for type two diabetes patients, working alongside diet and exercise to mitigate high blood sugar.
Mechanism of Action
It combines two agents that improve pancreatic hormone secretion and decrease the amount of glucose produced by the liver.
Route of Administration
Oral
Onset Time
Variable
Duration
12–24 hours
Contraindications
Severe renal disease, Metabolic acidosis
Severe Adverse Events
Lactic acidosis, Severe allergic skin reactions
Common Side Effects
Nausea, Metallic taste
Uncommon Side Effects
Stomach upset, Fatigue
Drug Interactions
Sulfonylureas, Insulin
Pregnancy Safety Warnings
Use only if clearly needed.
Age Restrictions
Adult use typically advised.
Storage Guidelines
Store at room temperature below 30°C.
Related Products
Janumet

Istamet FAQ

How do digital health platforms facilitate evaluation and access to Istamet in Singapore?

Digital health platforms provide educational resources and tele-consultation services that allow patients to consult with professionals who verify clinical suitability before recommending access options for Istamet.

Why are there cost variations between multi-source generic formulations and originator brands?

Cost variations generally reflect differences in manufacturing processes, overhead expenses, and economic factors, rather than a discrepancy in the bioequivalence of the active ingredients within a generic brand like Istamet.

How can patients in Singapore verify the regulatory compliance of digital health directories?

Verification involves checking the directory’s compliance status with the Health Sciences Authority (HSA) and ensuring the entity operates within the established regulatory guidelines for medical information and supply coordination.

What are the logistical considerations when utilizing cross-border facilitation for personal medication?

Utilizing cross-border services for personal medicine necessitates adherence to HSA import regulations, which may require specific documentation and strict limitations on the quantity of medication brought into Singapore.

How does the bioequivalence of Istamet compare to other Sitagliptin and Metformin combinations?

As a bioequivalent product, Istamet is designed to provide the same clinical effectiveness and safety profile as other formulations containing the identical active ingredients, ensuring consistent results for patients.

What is Istamet?

Managing blood glucose levels requires precise coordination between biological markers and therapeutic interventions. Istamet functions as a dual-action oral therapeutic agent formulated to support individuals diagnosed with type 2 diabetes. By combining two distinct chemical compounds, this medication addresses multiple physiological pathways involved in glucose metabolism and insulin regulation.

Clinicians identify this formulation as an essential tool for glycemic control when traditional lifestyle modifications prove insufficient. Consistent management of blood glucose levels facilitates better long-term health outcomes for patients needing regulated metabolic support. Health professionals monitor the patient's baseline indicators to ensure that the chosen therapeutic approach aligns with their specific metabolic requirements.

Regulatory & Classification Profile

Istamet is classified as a Prescription-Only Medicine (POM) within the regulatory framework of Singapore. Regulatory oversight in this jurisdiction ensures that individuals access such therapeutic agents only under the guidance and supervision of qualified medical professionals. Compliance with Health Sciences Authority (HSA) guidelines dictates the supply and distribution protocols for this compound.

Formulations & Associated Medications

Istamet serves as a bioequivalent generic brand formulation containing the active ingredients Sitagliptin and Metformin. Available formulations accessible through digital health directories include Istamet pill in strengths of 50/1000mg.

Therapeutic Applications

Management of type 2 diabetes mellitus remains the primary clinical focus for individuals requiring these targeted chemical agents.

  • Assists in the regulation of blood sugar levels following meals.
  • Addresses insulin resistance within peripheral tissues.
  • Supports the reduction of hepatic glucose production.
  • Manages sub-optimal glycemic control when single-agent therapy is insufficient.
  • Provides comprehensive support for patients requiring multi-pathway metabolic intervention.

Biological Action

These chemical agents work by influencing how the body processes energy. One component stimulates the release of natural substances that increase insulin production when blood sugar rises. The other component reduces the amount of glucose produced by the liver and improves the sensitivity of body tissues to the insulin already present. Together, these actions lower overall blood glucose concentration without significantly increasing the risk of low sugar events.

Treatment Landscape & Drug Class

Sitagliptin and Metformin belong to the biguanide and dipeptidyl peptidase-4 (DPP-4) inhibitor classes, respectively. Modern therapeutic protocols often combine these classes to manage metabolic dysfunction by targeting both insulin deficiency and peripheral resistance. Such combination therapies are foundational in current diabetes care, as they offer complementary mechanisms to improve patient outcomes over time.

Understanding the Safety Profile

Physiological processes surrounding these compounds involve hepatic clearance and renal filtration pathways, necessitating proper organ function monitoring. Systemic effects primarily concern the gastrointestinal tract and metabolic homeostasis, which remain central to how the body processes these ingredients. Maintaining hydration and following clinical monitoring schedules are essential for those utilizing these therapies. Refer to the clinical data tables provided for specific contraindications, interactions, and potential reactions.

Clinical Disclosure

Understanding the role of medications like Istamet requires acknowledging that therapeutic effectiveness depends on individual biology and strict adherence to professional guidance. While digital health platforms facilitate access to information regarding diverse formulations, such resources do not replace a face-to-face consultation. Please recognize that clinical outcomes vary, and liability for personal health decisions rests with the patient. Always verify labeling details and seek counsel from a practitioner before initiating treatment.

Clinical Glossary

Biguanide
A class of pharmacological agents that improve glucose tolerance by lowering both basal and postprandial plasma glucose.
DPP-4 Inhibitor
A specific type of medication that enhances the body's ability to lower blood glucose by prolonging the action of incretin hormones.
Glycemic Control
The term used to describe the monitoring and regulation of blood glucose concentrations within a target range.
Insulin Resistance
A condition where cells in the muscles, fat, and liver do not respond well to insulin and cannot easily take up glucose from the blood.
Information associated with Istamet is curated and periodically reviewed using established medical references and prescribing guidelines. Content is intended for general awareness and should be verified with a licensed healthcare professional before use.
Categories